Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Examine 30-day measures of substance use, overdose experiences, and number of “protected” opioid use events, defined as involving naloxone and the presence of another person who could administer it

Original research | 2022
Harm reduction, About PWUD, Social benefits, Overdose, Illegal drugs, Equity

This study aims to understand the implications that this has for the life circumstances and risk management of people who use drugs in areas of low access.

Original research | 2022
Harm reduction, Barriers and enablers, About PWUD, Stigma, Illegal drugs

This rapid review sought to summarize the retention rates reported by randomized controlled trials (RCTs) and controlled observational study designs that compared methadone to buprenorphine (or bup

Lit review | 2021
Substitution/OAT, Outcomes, About PWUD

Assess whether supervised consumption clients use methadone, or whether their use of methadone prevents opioid overdose.

Thesis | 2022
Substitution/OAT, About PWUD, SCS/OPS, Overdose, Illegal drugs

To examine potentially unsafe tapering and discontinuation among dosage changes in opioid prescriptions dispensed to US patients on high-dose long-term opioid therapy.

Original research | 2022
About PWUD, Withdrawal

We aimed to evaluate the association between benzodiazepine use in the first trimester of pregnancy and the risk of major congenital malformations.

Original research | 2022
Sex/Gender , Outcomes, Parents/caregivers

Among recipients of opioid agonist therapy (OAT) in Ontario, Canada, early in the COVID-19 pandemic, was there an association between dispensing of increased take-home doses and treatment retention

Original research | 2022
Policy/Regulatory, Substitution/OAT, Overdose, Evidence base, Carries/take-home doses
Revue de la littérature | 2022
à propos des personnes qui utilisent des drogues, l'équité

Peer Support Responders were trained under the Overdose Prevention & Resuscitation (CPR-OPR) program.

Report | 2022
Peer/PWLLE program involvement, Overdose

Investigated the impact of the expansion in eligibility for take-home doses on trends in the distribution of take-home doses of OAT during COVID-19.

Original research | 2022
Substitution/OAT, Policy/Regulatory, Overdose, Evidence base, Carries/take-home doses

This study explored: (1) the experiences of care of regional and rural clients of an Australian national online text-based substance use counseling service, Counselling Online; (2) their reasons fo

Original research | 2022
Digital health, Rural/remote, Barriers and enablers, About PWUD

The national trends, geographic distribution, and health risks of Xylazine in combination with other substances are poorly characterized.

Original research | 2022
Overdose, About PWUD, Illegal drugs, Drug checking

This systematic review reports on the features and findings of research on interventions developed specifically to improve substance use outcomes and treatment linkage after inpatient detoxificatio

Lit review | 2022
Transitions in care/treatment

Little is known about what happens on scene during an overdose call for service from an officer’s perspective, including what officers perceive their duties and responsibilities to be as the incide

Original research | 2022
Legal system/law enforcement, Policy/Regulatory, Overdose, Barriers and enablers

This study describes the perspective of professionals in the field of opioid use disorder (OUD), in the province of Quebec (Canada), regarding appropriateness of iOAT for their patients and the obs

Original research | 2022
About prescribers, Safer supply

We aimed to develop and assess the predictive validity of health system performance measures for opioid use disorder (OUD) in British Columbia (BC), Canada.

Original research | 2022
Policy/Regulatory

The purpose of this study was to identify the extent to which Missouri recovery houses were accepting of methadone, buprenorphine, and naltrexone as well as the extent to which the acceptance of ea

Original research | 2022
Housing, Transitions in care/treatment, Substitution/OAT

We set out to identify the facilitators and barriers that shape whether people experiencing homelessness initiate medications for opioid use disorder (MOUDs), both generally and after an overdose.

Original research | 2022
Housing, Transitions in care/treatment, About PWUD, Barriers and enablers

Low-barrier-to-treatment-access programs may be particularly effective at attracting patients experiencing homelessness into MMT; however, the literature on retention in such settings is limited.

Original research | 2022
Housing, About PWUD, Transitions in care/treatment, Substitution/OAT

Affiner votre recherche

Mots clés
Format
Région